Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Peris

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Tumori|February 24, 2001
Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: a pilot studyG Ferrara, G Argenziano, H P Soyer, et al.
The British Journal of Dermatology|January 30, 2004
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological studyI Zalaudek, G Argenziano, G Ferrara, et al.
Archives of Dermatology|January 16, 2002
Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimensD Piccolo, H Peter Soyer, W Burgdorf, et al.
The British Journal of Dermatology|March 3, 2020
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort studyA V Marzano, G Genovese, G Casazza, et al.
The British Journal of Dermatology|January 17, 2021
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differencesC Dessinioti, A C Geller, A Stergiopoulou, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2023
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox studyJ-M L'Orphelin, J Cassecuel, L Kandolf, et al.
The British Journal of Dermatology|October 1, 2020
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)A Wollenberg, A Blauvelt, E Guttman-Yassky, et al.
Expert Opinion on Biological Therapy|December 18, 2023
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort studyA Chiricozzi, S M Ferrucci, L Di Nardo, et al.
Archives of Dermatological Research|June 8, 2021
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter studyA Campanati, T Bianchelli, R Gesuita, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 19, 2023
Gender differences in adult atopic dermatitis and clinical implication: Results from a nationwide multicentre studyA Marani, T Bianchelli, R Gesuita, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Tumori|February 24, 2001
Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: a pilot studyG Ferrara, G Argenziano, H P Soyer, et al.
The British Journal of Dermatology|January 30, 2004
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological studyI Zalaudek, G Argenziano, G Ferrara, et al.
Archives of Dermatology|January 16, 2002
Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimensD Piccolo, H Peter Soyer, W Burgdorf, et al.
The British Journal of Dermatology|March 3, 2020
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort studyA V Marzano, G Genovese, G Casazza, et al.
The British Journal of Dermatology|January 17, 2021
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differencesC Dessinioti, A C Geller, A Stergiopoulou, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2023
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox studyJ-M L'Orphelin, J Cassecuel, L Kandolf, et al.
The British Journal of Dermatology|October 1, 2020
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)A Wollenberg, A Blauvelt, E Guttman-Yassky, et al.
Expert Opinion on Biological Therapy|December 18, 2023
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort studyA Chiricozzi, S M Ferrucci, L Di Nardo, et al.
Archives of Dermatological Research|June 8, 2021
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter studyA Campanati, T Bianchelli, R Gesuita, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 19, 2023
Gender differences in adult atopic dermatitis and clinical implication: Results from a nationwide multicentre studyA Marani, T Bianchelli, R Gesuita, et al.
Pageof 14